tiprankstipranks
Trending News
More News >

Orchard Therapeutics downgraded to Hold from Buy at Stifel

Stifel downgraded Orchard Therapeutics to Hold from Buy with a $16 price target after Kyowa Kirin announced a deal to acquire Orchard for $16 per American Depositary Share, or ADS, in cash, along with an additional contingent value right, or CVR, of $1.00 per ADS.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on ORTX:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue